ACATOTCServices-Educational ServicesFiscal year ends December 31
NP Life Sciences Health Industry Group Inc.
Financials through Q4 FY2023, quarter ended Dec 31, 2023Last filing: 10-K on Apr 16, 2024
$10.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $429.60M
- P/E (TTM)
- –
- Dividend yield
- –
NP Life Sciences Health Industry statistics
Financials through Dec 31, 2023, price as of Oct 19, 2026, median of Services-Educational Services companies for comparison
Valuation
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Market Cap | $429.60M | $131.21M |
| Enterprise Value | $429.53M | $108.95M |
| PS Ratio | 2609.60 | 1.66 |
Enterprise value
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| EV / Sales | 2609.18 | 1.39 |
Income (trailing twelve months)
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Revenue | $164.62K | $80.06M |
| Operating Income | -$690 | -$46.58K |
| Pretax Income | -$1.34K | -$27.47K |
| Net Income | -$2.94K | -$27.47K |
| EBITDA | -$690 | -$46.58K |
| EPS (Diluted) | $0.00 | $0.00 |
Margins
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Operating Margin | -0.42% | -5.92% |
| Pretax Margin | -0.81% | -2.62% |
| Profit Margin | -1.78% | -8.20% |
| EBITDA Margin | -0.42% | -3.87% |
Returns
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Return on Equity (ROE) | -15.2% | 2.84% |
| Return on Assets (ROA) | -2.87% | -2.87% |
| Return on Capital Employed (ROCE) | -1.78% | -1.78% |
Growth
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 61.4% | 3.64% |
| Revenue Growth (3Y CAGR) | 122.2% | 6.72% |
Balance sheet
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $70.61K | $13.92M |
| Net Cash (Debt) | $70.61K | $4.75M |
| Net Cash Per Share | $0.00 | $0.18 |
Financial position
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Quick Ratio | 1.85 | 0.89 |
| Interest Coverage | -1.07 | 5.21 |
Cash flow (trailing twelve months)
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Operating Cash Flow | -$73.61K | $40.74K |
Efficiency
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Asset Turnover | 1.61 | 0.82 |
Dividends and yields
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Earnings Yield | -0.00% | -0.48% |
Shares
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Shares Outstanding | 42,959,600 | 23,396,700 |
| Shares Change (YoY) | 0.00% | 0.13% |
| Float | 42,959,600 | 22,997,150 |
| Shares Held by Insiders | 0.00% | 12.8% |
Taxes
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Income Tax | $1.60K | $1.27M |
Scores
| Measure | NP Life Sciences Health Industry | Industry median |
|---|---|---|
| Altman Z-Score | 4257.42 | 2.86 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from NP Life Sciences Health Industry's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.